AAAAAA
Results: 26-33/33
Authors:
Bressolle, F
Joulia, JM
Pinguet, F
Ychou, M
Astre, C
Duffour, J
Gomeni, R
Citation: F. Bressolle et al., Circadian rhythm of 5-fluorouracil population pharmacokinetics in patientswith metastatic colorectal cancer, CANC CHEMOT, 44(4), 1999, pp. 295-302
Authors:
Ychou, M
Duffour, J
Pinguet, F
Kramar, A
Joulia, JM
Topart, D
Bressolle, F
Citation: M. Ychou et al., Individual 5FU-dose adaptation schedule using bimonthly pharmacokinetically modulated LV5FU2 regimen: A feasibility study in patients with advanced colorectal cancer, ANTICANC R, 19(3B), 1999, pp. 2229-2235
Authors:
Audran, M
Gareau, R
Matecki, S
Durand, F
Chenard, C
Sicart, MT
Marion, B
Bressolle, F
Citation: M. Audran et al., Effects of erythropoietin administration in training athletes and possibleindirect detection in doping control, MED SCI SPT, 31(5), 1999, pp. 639-645
Authors:
Guitton, C
Kinowski, JM
Abbar, M
Chabrand, P
Bressolle, F
Citation: C. Guitton et al., Clozapine and metabolite concentrations during treatment of patients with chronic schizophrenia, J CLIN PHAR, 39(7), 1999, pp. 721-728
Authors:
Benramdane, L
Bressolle, F
Vallon, JJ
Citation: L. Benramdane et al., Arsenic speciation in humans and food products: A review, J CHROM SCI, 37(9), 1999, pp. 330-344
Authors:
Lagorce, P
Perez, Y
Ortiz, J
Necciari, J
Bressolle, F
Citation: P. Lagorce et al., Assay method for the carboxylic acid metabolite of clopidogrel in human plasma by gas chromatography mass spectrometry, J CHROMAT B, 720(1-2), 1998, pp. 107-117
Authors:
Guitton, C
Abbar, M
Kinowski, JM
Chabrand, P
Bressolle, F
Citation: C. Guitton et al., Multiple-dose pharmacokinetics of clozapine in patients with chronic schizophrenia, J CL PSYCH, 18(6), 1998, pp. 470-476
Authors:
Bressolle, F
Gomeni, R
Citation: F. Bressolle et R. Gomeni, Predictive performance of a semiparametric method to estimate population pharmacokinetic parameters using NONMEM, J PHAR BIOP, 26(3), 1998, pp. 349-361